Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

NCT03182426 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Plerixafor
DRUG: Alemtuzumab
DRUG: Anakinra
DRUG: Etanercept
DRUG: Liraglutide

Sponsor

University of Alberta

Collaborators

[object Object]